Blog: PANACEA LIFE SCIENCES HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01. Regulation FD Disclosure.

On May 3, 2022, Ms. Leslie Buttorff, Chief Executive Officer of Panacea Life
Sciences Holdings, Inc. made a presentation to certain members of the investment
community. A copy of such presentation is being furnished herewith as Exhibit
99.1 to this report.

The information in this Item 7.01 of this report, including the information in
the presentation attached as Exhibit 99.1 to this report, is furnished and shall
not be deemed “filed” for the purposes of Section 18 of the Securities Exchange
Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that
section. Furthermore, the information in Item 7.01 of this report, including the
information in the presentation attached as Exhibit 99.1 to this report, shall
not be deemed to be incorporated by reference in the filings of the registrant
under the Securities Act of 1933, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits




(d) Exhibits.



Exhibit No.   Exhibit

99.1            Investor Presentation

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s